Skip to main content
. 2015 May 6;12(106):20141000. doi: 10.1098/rsif.2014.1000

Table 1.

ON–OFF switches in mammalian synthetic biology.

switch levela no. name ON switchb OFF switchc origin effectord applications references
 transcriptional switches
1 ABA yes no Arabidopsis thaliana, yeast abscisic acid gene therapy, experimental tool to control diverse cellular activities in vivo [19]
2 AIR yes no Aspergillus nidulans acetaldehyde gas-adjustable transgene expression, biopharmaceutical manufacturing [20]
3 ART yes no Chlamydia pneumoniae l-arginine biopharmaceutical manufacturing, gene therapy [21]
4 BEARON, BEAROFF yes yes Campylobacter jejuni bile acid gene- and cell-based therapies [22]
5 BirA-tTA no yes Escherichia coli biotin (vitamin H) biopharmaceutical manufacturing, cell therapy [23]
6 BIT yes no Escherichia coli biotin (vitamin H) gene therapy, tissue engineering, biopharmaceutical manufacturing [24]
7 Cry2-CIB1 yes no Arabidopsis thaliana, yeast blue light protein translocation, transcription control, Cre-mediated DNA recombination using light [25]
8 CTA, CTS yes yes Comamonas testosteroni, Homo sapiens food additives (benzoate, vanillate) gene- and cell-based therapy [26]
9 cTA, rcTA yes yes Pseudomonas putida cumate regulation of gene expression level and duration [27]
10 Ecdysone yes no Homo sapiens, Drosophila melanogaster Ecdysone transient inducible expression, gene therapy [28]
11 EcR:RXR yes no Homo sapiens, Locusta migratoria ecdysone ligand-dependent induction of reporter gene, gene therapy [29]
12 electro-genetic yes no Aspergillus nidulans electricity, acetaldehyde electric power-adjustable transcription control; mammalian cell-based control of microelectronic circuits [30]
13 ER-p65-ZF yes no Homo sapiens, yeast 4,4′-dyhydroxybenzil generating a wide array of orthogonal gene switches [31]
14 E.REX yes yes Escherichia coli erythromycin gene therapy, tissue engineering, in vivo gene-function analyses, drug discovery, biopharmaceutical manufacturing [32]
15 EthR no yes Mycobacterium tuberculosis 2-phenylethyl-butyrate drug discovery [33]
16 GAL4-ER yes yes yeast, Homo sapiens oestrogen, 4-hydroxytamoxifen regulating heterologous genes, identifying Fos (oncogene) targets [34]
17 GAL4-hPR yes yes yeast, Homo sapiens mifepristone positive and negative regulation of gene expression, also in vivo [35,36]
18 GAL4-Raps yes yes yeast, Homo sapiens rapamycin and rapamycin derivatives targeted gene expression control [37]
19 GAL4-TR yes no yeast, Homo sapiens thyroid hormone study nuclear receptor signalling [38]
20 GyrB yes yes Escherichia coli coumermycin, novobiocin rapid regulation of gene expression [39]
21 HEA-3 yes no Homo sapiens 4-hydroxytamoxifen gene therapy [40]
22 Intramer no yes synthetic SELEX-derived aptamers theophylline controlling transgene expression, construction of complex gene networks [41]
23 LacI yes no Escherichia coli IPTG reversible regulation of gene expression, predictable levels of de-repressed gene expression [4246]
24 LAD yes no Arabidopsis thaliana, yeast blue light light-controlled gene expression regulation; protein hetero- and homo-dimerization induced by light [47]
25 LightOn yes no Neurospora crassa, yeast blue light light-switchable transcription control [48]
26 NICE yes yes Arthrobacter nicotinovorans 6-hydroxynicotine therapeutic cell engineering, biopharmaceutical manufacturing [49]
27 PPAR* yes no Homo sapiens rosiglitazone gene therapy [50]
28 PEACE no yes Pseudomonas putida flavonoids (e.g. phloretin) biopharmaceutical manufacturing, gene- and cell-based therapies [51]
29 PIT yes yes Streptomyces coelicolor pristinamycin I, virginiamycin compatible with the Tet-OFF system, thus two different gene activities can be controlled in the same cell [12]
30 REDOX no yes Streptomyces coelicolor NADH process development, biopharmaceutical manufacturing [52]
31 QuoRex yes yes Streptomyces coelicolor, Streptomyces pristinaespiralis butyrolactones (e.g. SCB1) small molecule-adjustable gene control systems for clinical application [53]
32 ST-TA yes yes Streptomyces coelicolor, Escherichia coli, Herpes simplex γ-butyrolactone, tetracycline Design of therapeutic gene circuits for gene and cell-based therapies [54]
33 TIGR no yes Streptomyces albus temperature temperature-inducible gene regulation [55]
34 TraR yes no Agrobacterium tumefaciens N-(3-oxo-octanoyl)homoserine lactone versatile gene expression control [56]
35 TET-OFF, TET-ON yes yes Escherichia coli, Herpes simplex tetracycline, doxycycline reversible and tight gene expression control [11,57]
36 TRT yes no Chlamydia trachomatis l-tryptophan synthetic bidirectional communication between mammalian cells [58]
37 UREX yes no Deinococcus radiodurans uric acid self-sufficient control of pathologic metabolites, gene- and cell-based therapies [59]
38 VAC yes yes Caulobacter crescentus vanillic acid biopharmaceutical manufacturing, gene- and cell-based therapies [60]
39 ZF-ER, ZF-RXR/EcR yes yes Mus musculus, Homo sapiens, Drosophila melanogaster 4-hydroxytamoxifen, ponasterone-A spatio-temporal control of gene expression, genomic and proteomic research, gene therapy [61]
40 ZF-Raps yes no Homo sapiens rapamycin gene expression control, gene therapy [62]
41 ZF switches yes no Mus musculus, Homo sapiens, Drosophila melanogaster 4-hydroxytamoxifen, mifepristone study of gene function, alteration of phenotypes of cells or organisms [63]
42 ZF(TF)s yes no Xenopus laevis, Homo sapiens ethyl-4-hydroxybenzoate, propyl-4-hydroxybenzoate genomic and proteomic research, gene therapy [64]
 post-transcriptional switches
1 aptamer RNAi yes no synthetic SELEX-derived aptamer theophylline regulation of gene expression by small molecules without engineered proteins [65]
2 aptamer RNAi no yes synthetic SELEX-derived aptamer theophylline construction of conditional RNAi systems [66]
3 aptamer RNAi miRNA yes no synthetic SELEX-derived aptamer theophylline, tetracycline, hypoxanthine probing and programming of cellular function [67]
4 aptamer Splicing yes yes Homo sapiens, MS2 bacteriophage MS2, p65, p50, b-catenin programmable sensing-actuation devices for autonomous cell behaviour control [68]
5 aptazyme no yes synthetic SELEX-derived aptamer, Schistosoma mansoni theophylline regulation of therapeutic gene expression [69]
6 replicon CytTS yes no Sindbis virus temperature expression of toxic proteins, bioprocess engineering [70]
7 TET-OFF-shRNA, TET-ON-shRNA yes yes Escherichia coli, Herpes simplex, Homo sapiens doxycycline basic or translational research, development of gene-based therapeutics [71]
8 theo aptamer no yes synthetic SELEX-derived aptamer theophylline basic, biotechnological, and biomedical research [72]
9 3′ UTR aptazyme yes no synthetic SELEX-derived aptamers, tobacco ringspot virus theophylline, tetracycline functional response regulation, gene and cellular therapy [73]
10 5′ UTR aptazyme no yes synthetic SELEX-derived aptamer, Schistosoma mansoni theophylline control of gene expression, gene therapy [74]
 translational switches
1 Hoechst aptamer no yes synthetic RNA sequence Hoechst dyes translational gene regulation, biology and medical research [75]
2 H23 aptamer no yes Archaeoglobus fulgidus L7Ae, L7KK gene expression regulation, construction of a NOR gate [76]
3 L7Ae aptamer yes yes Archaeoglobus fulgidus L7Ae detection, repair or rewiring of intrinsic cellular defects, characterization of complex circuits [77]
4 MS2 aptamer no yes MS2 bacteriophage MS2 study RNA–protein interactions, clone RNA-binding proteins [78]
 post-translational switches
1 AID no yes Arabidopsis thaliana, Oryza sativa, Gossypium hirsutum auxins (e.g. IAA) control protein expression and study protein function [79]
2 ER DD no yes Homo sapiens CMP8, 4-hydroxytamoxifen regulate the intracellular concentration of any protein [80]
3 FM yes no Homo sapiens AP21998 delivery of polypeptides that require rapid and regulated delivery [81]
4 HaloTag no yes Rhodococcus sp. RHA1 HyT13 validating potential drug targets in disease models [82,83]
5 HDV-aptazyme no yes hepatitis delta virus theophylline, guanine dynamic range of gene regulation [84]
6 PROTAC no yes Homo sapiens proteolysis targeting chimeric molecules (PROTACS) chemical knockouts, control of protein function [85]
7 shield DD yes no Homo sapiens shields (e.g. Shld1) conditional control of proteins levels [86]
8 shield LID no yes Homo sapiens shields (e.g. Shld1) conditional control of proteins levels [87]
9 TMP DD yes no Escherichia coli trimethoprim (TMP) tuneable regulation of protein expression in the mammalian central nervous system [88]

aLevel of gene expression where the switching occurs.

bON switchability by an effector; other than removing the effector which confers the OFF state.

cOFF switchability by an effector; other than removing the effector which confers the ON state.

dA ligand or other physical stimuli (e.g. temperature, electromagnetic radiation, electricity) which stabilizes the switch either in its ON or OFF state.